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Purpose: The Action Plan for Medication Safety by the German Federal Ministry of Health 
introduced a standardized medication plan (MP), a printable document for the patient. The practi-
cal handling needs to be tested before the nationwide implementation in Germany. Therefore, 
the aims of our study were 1) to develop an instrument to evaluate the usage of the standardized 
MP, 2) to assess if patients can locate, and 3) understand important information. Moreover, we 
explored patients’ opinion and suggestions regarding the standardized MP template.
Patients and methods: We conducted a cross-sectional study to evaluate the practical handling 
of the standardized MP. We interviewed 40 adult patients in seven community pharmacies in 
Germany, who took at least five medicines regularly and gave their written informed consent. 
The interview consisted of questions regarding finding and understanding information provided 
on a mock-up MP, patients’ opinion and the execution of the information on the MP by filling 
pill boxes. We eventually developed a new evaluation method to quantify the practical handling 
of the MP by rating the pill boxes filled by the patients.
Results: Overall, the participants rated the MP positively. Thirty-nine (98%) participants found 
important information on a mock-up standardized MP. Patients were questioned to identify if they 
understood information on medical intake as it relates to meals. In particular, they were ques-
tioned about medicine intake “1 hour before a meal”, which 98% (n=39) interpreted correctly, 
and “during a meal”, which 100% (n=40) interpreted correctly. The less precise advice of “before 
a meal” was interpreted correctly by 73% (n=29), and only 15% (n=6) correctly interpreted the 
term “after the meal”. The evaluation of the filled pill boxes resulted in the “Evaluation Tool 
to test the handling of the Medication Plan” (ET-MP) – a weighted scoring system.
Conclusion: The standardized MP is clearly arranged, and patients are able to find important 
information. The findings of this study resulted in minor but important revisions of the standardized 
MP template. The developed evaluation tool ET-MP may serve as an objective instrument to assess 
patients’ ability to transfer written information on the MP into practical handling of medicines.
Keywords: medication plan, medication schedule, ET-MP, Action Plan for Medication Safety, 
Germany, patient safety, pharmacotherapy
Introduction
The communication of medicines information is critical not only for the safe use of 
medicines but also, eventually, for patients’ medication adherence and pharmacother-
apy outcomes. Patients often misunderstand the content of physicians’ or pharmacists’ 
recommendations during counseling or they tend to forget the given information.1–4 
For example, 40%–80% of the given information seems to be forgotten immediately.5 
Patients especially fail to remember instructions on treatment.6 These facts may lead 
to patients’ unawareness of how to take or administer their medication. For patient 
safety, it is crucial that patients know how to administer their medicines.
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In general, patients better remember verbal information 
combined with written information than oral information 
alone.7 The literature suggests that personalized prescrip-
tion drug labels, containing information on, eg, dosing, may 
play an important role in the appropriate administration of 
medicines.8 But labels are effective only if people under-
stand them, and poorly designed drug labels are even cited 
as a leading cause for medication errors by the American 
Institute of Medicine, among others.9,10 In Germany, patients 
do not get personalized prescription drug labels to provide 
important information. Physicians are also not obligated 
to write dosages or medical indications on prescriptions, 
making it difficult for both patients and pharmacists to 
have a complete and comprehensive overview. Hence, in 
general, patients only receive selected information on their 
medication by the prescribing physician or the dispensing 
pharmacist during counseling. German studies assessing the 
characteristics of patients’ medication lists showed that only 
7% were complete and up to date.11 They were also corrected 
manually leaving them unreadable,12 thus showing the need 
for a standard.
The medication plan
A medication plan (MP) is defined as a printable document 
for the patient that specifies the complete medication, instruc-
tions, and indications. The MP is supposed to facilitate the 
correct administration of the medication after counseling in 
the pharmacy.13 The Action Plan for Medication Safety,14 
initiated by the German Federal Ministry of Health, intro-
duced a standardized MP template not only to aid patients 
but also to inform health care professionals about a patient’s 
complete medication.15 The MP template includes prescrip-
tion and nonprescription drugs and specifies the dosing regi-
men. This MP is going to be implemented in Germany by 
the so-called E-Health law, which became effective January 
1, 2016 (§ 31 a Social Code Book V [Sozialgesetzbuch V 
{SGB V}] – medication plan).16 Patients in the ambulatory 
setting insured with a statutory health insurance (~90% of 
the population), taking at least three prescribed medicines, 
are entitled to receive a paper-based MP from October 2016 
onward.16 For the time being, the MP is issued by the prescrib-
ing physician and shall be updated by the pharmacist during 
dispensing, if needed and upon patients’ request, especially 
with regard to nonprescription pharmacy-only medicines.
Several publications identified a medication list as a 
relevant patient safety indicator.17–19 The MP can be consid-
ered as a combination of a medication list and the information 
on a personalized prescription drug label.
Like drug labels, an MP can only contribute to medication 
safety if patients can read and understand it. It is currently 
unknown if patients understand the standardized MP and 
can handle it. Therefore, the practical handling of the MP 
needs to be tested before implementation. To the best of our 
knowledge, no appropriate method exists to test patients’ 
understanding and handling of an MP.
Therefore, the aims of our study were 1) to develop a new 
evaluation method to quantify the practical handling of the 
MP and 2) to evaluate if patients can find important informa-
tion on the standardized MP and 3) can understand the com-
mon administering information regarding drug intake related 
to meals. Moreover, we aimed to explore patients’ opinion 
and suggestions regarding the standardized MP template.
Methods
We conducted a cross-sectional study to evaluate the practi-
cal handling of the standardized MP,15 using semistructured 
interviews including a practical approach. In our survey, we 
also collected demographic data of the participants, eg, age 
and level of education. The comprehensibility of the inter-
view questions was piloted with four patients. This resulted in 
no change of the interview guide (Supplementary materials – 
in German and English).
Patients were eligible if they were 18 years or older, could 
understand and speak the German language, and gave their writ-
ten informed consent. Furthermore, patients had to take at least 
five medicines regularly (prescription and nonprescription), 
as this is the most common definition for polymedication,20–22 
and these patients are the main target group for the MP. The 
draft of the law on E-Health referred to at least five prescribed 
medicines as the threshold to receive a written MP. This, 
however, changed to three drugs during the parliamentary 
process. Exclusion criteria were any completed formal medical 
or pharmaceutical education and limited eyesight or hearing. 
Participants were recruited by community pharmacists. Seven 
pharmacies in different regions of Germany – rural and urban 
areas – participated in the study. They addressed appropri-
ate patients and made an appointment for the interview. The 
interview was then conducted by one of the authors (LB) in 
a separate room within the pharmacy. We aimed to include 
40 patients in total. A guideline for the readability testing of 
package leaflets by the European Commission suggests to 
include 20 patients in a user testing.23 Since this is the first study 
that addresses the standardized MP, we decided to double the 
number of patients. The study was approved by the responsible 
review board (data privacy commissioner in Berlin and Saxony, 
Germany [531.1636.11 and 2-P6805.1/4]).
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The face-to-face interview
The interviewer questioned the patients following a 
detailed survey guide (Supplementary materials) in a 
face-to-face interview, which took ~1 hour per patient. 
Topics were as follows: patients’ understanding, their 
opinion, and suggestions regarding the standardized 
MP. We used a mock-up MP (Figure S1) for the study, 
which was compiled based on previous experience. The 
mock-up MP exemplarily listed six medicines, including 
prescription and nonprescription drugs with the names of 
brand products (eg, omeprazole as Antra MUPS® [Astra 
Zeneca GmbH, Wedel, Germany]) as well as generic 
names (eg, metoprolol succinate as Metoprololsuccinat-1A 
Pharma® [1A Pharma, Oberhaching, Germany]). The 
medicines had different medical indications, eg, chronic 
heart failure and pain. The dosing regimens covered all 
times of the day (morning, noon, afternoon, at bedtime) 
and a once-weekly administration (methotrexate). Most 
active ingredients were common in the general patient 
population, eg, metoprolol or magnesium. Administering 
information on the mock-up MP was selected randomly 
from a larger list and was easy to understand, eg, “take 
with a glass of water”. The patients were also questioned 
about their attitude toward the MP. They were given four 
statements: “The MP is clearly arranged”; “The MP would 
help me to take my medication appropriately”; “I would 
use an MP if my doctor or pharmacist would provide one 
for me”; and “I would take my MP to every doctors or 
pharmacy appointment/visit”. Then they had to state how 
much they agreed with the statement on a five-point Likert 
scale: ranging from yes (total agreement) to no (total dis-
agreement). The interviewer documented all comments the 
patient made regarding the MP. The results of the patient 
attitude survey questions are described as numbers and 
percentages. Comments are stated as quotes.
Patients had 2 minutes to familiarize themselves with the 
MP. The first step addressed the clear arrangement of the MP. 
Therefore, participants had to identify important information 
on the document: 1) the name of the MP’s author (Dr Helga 
Herz), 2) a medication line on the MP that corresponded to 
a medication package (omeprazole) shown to the patient, 
3) the displayed administering information to that medicine, 
and 4) the medical indication column. Participants were 
allowed to say the answer or point out where it was found, 
eg, the column. The answer was incorrect if the participant 
pointed out the wrong column/line or could not find the 
information at all (Supplementary materials). The answers 
were analyzed descriptively as numbers and percentages.
Patients’ understanding of the 
administering information
We also evaluated the patients’ understanding of the admin-
istering information, which is included in one column of the 
standardized MP template. The issue of medication intake 
around meals is an important part of patient counseling and 
if relevant also mentioned in package inserts and Summaries 
of Product Characteristics, also as a result of the approval 
process. Despite the clinical significance, if instructions 
are given, they should be understandable to patients and/or 
caregivers.24–26 Hence, we investigated the understandability 
of these instructions and suggested improvements. There is 
neither a universally valid description depicted in scientific 
literature nor standardized definitions for what exactly 
they mean. Especially for the information regarding drug 
intake related to meals, there is no set time frame for what, 
eg, “before meals” or “after meals” exactly means. Thus, 
we predefined the appropriate time frame for this study – 
according to clinical practice as well as our pharmacological 
and pharmacokinetic expertise (Figure 1).
We presented four different administering information 
regarding food intake (during the meal; during or after the 
meal; 1 hour before the meal; after the meal) to the patients. 
We then evaluated if the answers corresponded to the pre-
defined definitions.
The participants were given four timelines (Figure 1). 
Each timeline represented 1 day from 6 until 11 am. 
Figure 1 Timeline including the definitions of the administering information.
Notes: A, before the meal; B, 1 hour before the meal; C, during or after the meal; and D, after the meal.
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There was a pictogram marker for the mealtime at 9 am. The 
participants were then asked,
Imagine you take four tablets once daily in the morning. 
Your pharmacist gives you the four different administering 
information [one for each]. When would you take each 
tablet? Please indicate on the timeline.
They then marked the time on the four timelines. The drawn 
marks were compared to the predefined time frames and 
counted as correct if set within them. The results are given 
as numbers and percentages.
The practical approach of the interview
The second part of the interview had a practical approach. 
Participants received the medication packages correspond-
ing to the medicines listed on the MP (remark: in Germany, 
oral solid dosage forms are almost exclusively packed as 
blisters in a carton compared to prescription bottles). The 
medication packages were filled with different colored and 
shaped placebos including a paper pictogram representing 
30 drops (Figure 2). In addition, the mock-up MP (Figure S1) 
and two pill boxes were handed out for 2 days (Monday and 
Tuesday), representative of the whole week. The interviewer 
then asked,
Imagine your doctor has prescribed these six medicines and 
he issued this medication plan in order to assist you. It lists 
all drugs with the corresponding dose, dosing instructions, 
and the medical indication. The latter written in a language 
understandable for patients. I would like you to show, when 
[at what time of the day and weekday] you would take the 
medication. For that, please fill the pill boxes exemplary 
for two days (Monday and Tuesday) according to the given 
dosing regimen.
Participants needed to allocate the medication cartons to the 
corresponding lines on the MP. They had to find and under-
stand the dosing instruction for each medication. Finally, they 
needed to transfer this information into practice by filling the 
placebos into the compartments of the pill box (morning, 
noon, afternoon, at bedtime).
Development of the evaluation tool
We predefined the standard for the correct filling of the pill 
boxes and documented it in a picture (Figure 2). During the 
face-to-face interview, we also documented the results of 
each practical part by taking pictures. This documentation 
was the basis for the development of the evaluation instru-
ment (Table S1). We evaluated the deviations from the 
standard and assessed the clinical relevance based on our 
pharmaceutical and clinical experiences and expertise.
Results
A total of 40 patients, aged 28–83 years (median 67 years), 
55% female and representing the entire range of educational 
background, participated in the study. All completed the 
full interview. Patients’ characteristics are displayed in 
Table 1.
structure of the MP template – 
orientation on the MP
The author of the MP (1) was correctly depicted by 95% 
(n=38) of the participants. One cited the wrong name and 
one did not find this information on the MP. All of the 
Figure 2 Correctly filled pill box (standard of the practical part).
Notes: Openings: morning, noon, afternoon, at bedtime.
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participants (n=40) allocated the one medication package 
(omeprazole) (2) correctly to the appropriate line on the MP. 
The corresponding administering information (3) was found 
by 90% (n=36). One patient assigned wrong information to 
the omeprazole tablets. The other three could not find the 
column with the administering information at all. Ninety-
eight percent (n=39) of the participants completed the last 
task (4) successfully – to show where the information regard-
ing the medical indication is specified.
Patient attitudes survey
Overall, the participating patients rated the MP positively 
(Figure 3A and B). Thirty-five percent (n=14) were not 
completely satisfied with the MP design. For instance, eight 
patients preferred if the column with the active ingredient 
would be omitted and seven would swap the columns with 
the active ingredient and the brand name (first and second 
column). One patient stated “for me as a patient it’s unim-
portant what the active ingredient is. I can’t remember it 
[active ingredient] anyway; I can barely even pronounce it”. 
Another patient is concerned “I’m totally irritated with the 
brand name being second [on the MP]”. Thirty-five percent 
(n=14) indicating that they would “not or rather not” take 
their MP to every doctor’s appointment or pharmacy visit 
specified that they would not take it to their pharmacy because 
all their medication data are “saved there anyway”.
Patients’ understanding of the 
administering information
For the administering information “during or after the 
meal”, all participants (n=40) marked the timeline correctly 
(during–30 minutes after; Figure 1). Ninety-eight percent 
(n=39) of the patients understood the instruction “1 hour 
before the meal” right. “Before the meal”, defined as at least 
30 minutes before, was marked correctly by only 73% (n=29) 
of the participants. Only 15% (n=6) marked the timeline 
according to the set definitions for “after the meal” as at 
least 60 minutes later.
The evaluation tool (ET-MP)
The comparison of the documented (photographed) pill boxes 
with the standard (Figure 2) showed that there were several 
deviations. We decided that the simple assessment of com-
pletely correct versus not completely correct filled pill boxes 
did not fully describe the real handling of the MP. Therefore, 
we identified three criteria as relevant: quantity of the medi-
cine, day, and time of the day. These criteria needed to be 
applied to each day and medicine. For every day and drug, an 
evaluation matrix was created (Table S1). The results of the 
picture documentation were transferred into the matrix and 
rated according to the right/wrong principle (1/0). We judged 
that this simple assessment of the three criteria was also 
Table 1 Descriptive characteristics of the study group (n=40)
Characteristics Median (range) or n (%)
Age (years) 67 (28–83)
Female 22 (55)
highest completed educational degree
none 1 (2.5)
8/9 years 10 (25)
10 years 13 (32.5)
12/13 years 3 (7.5)
University 13 (32.5)
number of drugs 7 (5–17)
Possession of a medication lista 23 (57.5)




















Figure 3 Attitude survey.
Notes: (A) Statements and (B) results.
Abbreviation: MP, medication plan.





inadequate to represent the clinical relevance sufficiently. 
Hence, a refinement led to a weighted scoring system. This 
eventually resulted in the final version of the “Evaluation 
Tool to test the handling of the Medication Plan” (ET-MP) 
(Table 2). Correctness of the three aspects was assessed as 
right (quantity of the medicine =3 points, day =2 points, and 
time of the day =1 point) or wrong (0 points). The aspects 
were weighted depending on the potential extend of harm 
an error may cause.
To quantify the patients’ handling of the standardized MP, 
the ET-MP was applied to each day (Monday and Tuesday) 
and each medicine. For example, one medication is supposed 
to be taken every day morning and noon. The patient puts a 
placebo into the morning and instead of the noon opening of 
the pill box. The scoring would be as follows: 3 points for the 
correct interval and quantity (two times one tablet), 2 points 
for the correct day, and 0 points because it was the wrong 
time of the day. This would result in 5 out of 6 possible points 
for this selected drug and day. The total ET-MP score was 
calculated as the percentage of the sum of all medications for 
the 2 days. For the mock-up MP, this meant a maximum of 
36 possible points per day and 72 possible points overall. The 
ET-MP score would in this case be the percentage of 72.
Discussion
A complete and comprehensive plan of the current medica-
tion is considered to be of central importance for patient 
safety. We developed the ET-MP to evaluate the handling 
and practical usage of the standardized MP developed within 
the Action Plan for Medication Safety in Germany. To the 
best of our knowledge, this is the first evaluation tool to 
determine the usability of an MP. In addition, the results of 
the 40 interviews suggest that the current standardized MP 
template seems to be clearly arranged, and that patients’ 
understanding of administering information regarding food 
intake depends on the type of information given.
With the standardized MP, patients have one document 
that lists the complete medication including the dosing 
regimen, administering information, and medical indication. 
It has been shown that misunderstandings and medication 
errors can be avoided and medication reconciliation and 
adherence might be improved.27 Different international 
patient safety initiatives emphasize a medication list or 
schedule as a central patient safety indicator. They state that 
patients with multiple pharmacotherapy (polymedication) 
are urged to always have a complete list of all their medi-
cines with them.17,28 Send et al showed that an MP includ-
ing dosing and administering instructions can also support 
verbal instructions at hospital discharge, leaving patients 
significantly better informed;29 thus, making it also easier 
for the patients to take an active part in the decision-making 
process. A recent study, assessing characteristics of MP used 
by elderly ambulatory patients in Germany, showed that only 
a fraction already possessed an MP.12 Half of these MPs 
were amended manually with the risk to confuse both the 
user (patient or carer) and health care professionals.12 This 
supports the need for a nationally standardized MP.
For the developed MP standard15 to be usable, it is 
essential that it is clearly arranged and that patients can 
identify all the relevant information.30 In our study, almost 
all participants were able to find the important information 
on the MP. The participants had only minor suggestions for 
improvement.
As an important by-product of the interview, we found 
that the abbreviations used for representing the time of the 
day in the dosing column were unclear. The abbreviations 
“mo” and “mi” were misunderstood as Monday (German: 
Montag) and Wednesday (Mittwoch); instead of morning 
(German: morgens) and noon (mittags). The abbreviation 
“zN” for at bedtime (German acronym for zur Nacht) seemed 
not to be self-explanatory either. This resulted in confusion 
and uncertainty. Fifty percent (n=20) of the participants made 
comments indicating misunderstanding of the abbreviations; 
17.5% (n=7) did not understand the naming of the time of the 
day even after an explanation. This fact could be an important 
threat to patient safety. We therefore strongly recommend 
revising the standardized MP template and writing out the 
time of the day to avoid confusion.
Regarding administering information, there is neither a 
universally valid description depicted in scientific literature 
nor standardized definitions for what exactly they mean. 
Precise instructions, like “1 hour before the meal”, were 
understood correctly by almost all the participants. Vague 
wording of the administering information leads to widely 
spread answers of the participants. For example, for “before 
the meal” the answers reached from 5 to 90 minutes before 
the meal (median = 30). Gazmararian et al showed that over 
Table 2 The “evaluation Tool to test the handling of the 
Medication Plan” (ET-MP)
Criteria Correct Incorrect
Dosing interval including drug quantity 3 0
Day 2 0
Time of the day 1 0
Notes: Assessment criteria adjudged to be important. Applied to every drug on 
every day as a weighted point-based system.
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half of their participants could not answer “how to take 
medication on an empty stomach”.31 To promote medica-
tion safety, it is desirable and necessary to not only use 
precise instructions but also have standardized phrases for 
the MP.32
Davis et al showed that patients can better verbalize than 
demonstrate read information.4 This means though many 
patients can reproduce given information, they have not 
fully understood it (lack of comprehension). Therefore, our 
study applied a practical part in addition to the allocation 
of important information on the MP. We decided to look 
at 2 days (Monday and Tuesday) as representative for the 
entire week. By including 2 days compared to just 1 day, 
we intended to capture more complex dosing regimens, 
eg, once a week on Monday. It is possible that the results 
would differ if the test would include more days or even 
the whole week. But within this study, this was deemed 
not feasible.
We developed the ET-MP to evaluate the handling of 
MP by the patients. Therefore, we assessed every medicine 
and every day separately including three aspects rated as 
relevant. We found it necessary that the scoring height of the 
different aspects depends on the potential harm a medication 
error could cause, resulting in the weighted scoring system 
(Table 2). The final ET-MP score is the percentage of the 
individual points based on the maximum points.
The strength of our study is that we developed the first 
instrument to evaluate the handling of an MP with the help 
of the ET-MP. The ET-MP is easy to apply and to calculate, 
and patients appreciated this type of interview. None of the 
40 patients found the approach offensive. The instrument also 
seems applicable to study patients’ handling of an MP.
A limitation is that we did not assess health literacy of 
the study participants. But to the best of our knowledge, 
there is no validated tool to assess health literacy in German 
patients. We therefore included the participants’ level of 
education. A further limitation is that the tool was developed 
on a relatively small sample size. However, the European 
Commission only requires N=20 for package insert read-
ability testing. To assure the feasibility of the instrument 
as well as sufficient inter-rater reliability, it is desirable to 
further test the tool on a larger sample and even on patients 
with certain medical indications, such as applying the tool 
to patients suffering from, eg, chronic heart failure, diabetes, 
or depression. To determine the understandability of the MP, 
a cutoff needs to be defined on the basis of a greater sample. 
It should then be analyzed if certain patient characteristics 
are associated with the understandability of the MP. Another 
potential limitation of our study, due to the design, is an 
interviewer bias. We however considered the robust meth-
odology of a single interviewer to be superior to the risk of 
an interviewer bias in this pilot investigation and method 
development. We, furthermore, did not hypothesize the 
results and should have therefore avoided desired responses 
as much as possible.
Conclusion
Our research shows that the standardized MP15 is clearly 
arranged and patients are able to find important information 
on it. In general, the patients are satisfied with the MP and 
would appreciate if they obtained one. They see the need for 
a complete list of all their medication with the corresponding 
dosing regimen and administering information.
For the standardized MP, it is important to have standards 
not only regarding the format but also regarding the content, 
eg, the wording of administering information, which needs 
to be precise and understandable. For the future, it is desir-
able to conduct a further and broader test of the MP with the 
developed instrument, the ET-MP.
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Patients’ handling of a standardized medication plan
Supplementary materials
Figure S1 Mock-up medication plan (MP).
Notes: (A) English translation (not authorized). (B) Original MP in German as it was used in the study. The MPs display dummy data and do not represend a real patient’s 
information or medication.
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Table S1 “Evaluation Tool to test the handling of the Medication Plan” (ET-MP) evaluation example: two sample days with perfectly 
filled pill boxes (the standard)
Monday Tuesday
Drug (product) Interval plus quantity Day Time of day Interval plus quantity Day Time of day
Magnesium 3/3 2/2 1/1 3/3 2/2 1/1
Metoprolol succinate 3/3 2/2 1/1 3/3 2/2 1/1
Omeprazole 3/3 2/2 1/1 3/3 2/2 1/1
Methotrexate 3/3 2/2 1/1 3/3 2/2 1/1
Metamizole/Dipyrone 3/3 2/2 1/1 3/3 2/2 1/1
Baldriparan® 3/3 2/2 1/1 3/3 2/2 1/1
Notes: Data presented as points achieved/points possible. Result: 72/72 = 100% (ET-MP - Score). Assessment: The three aspects of the tool (interval plus quantity; day; time 
of day) are applied to every drug and every day, respectively. if the aspects are correct full points (3, 2 or 1) are given. If the aspects are wrong 0 points would be assigned.
